Pines M - Search Results

1

Inhibition of glomerular mesangial cell proliferation and extracellular matrix deposition by halofuginone.

Nagler A, Katz A, Aingorn H, Miao HQ, Condiotti R, Genina O, Pines M, Vlodavsky I. Nagler A, et al. Among authors: pines m. Kidney Int. 1997 Dec;52(6):1561-9. doi: 10.1038/ki.1997.486. Kidney Int. 1997. PMID: 9407501 Free article.

2

Inhibition of collagen type I synthesis by skin fibroblasts of graft versus host disease and scleroderma patients: effect of halofuginone.

Halevy O, Nagler A, Levi-Schaffer F, Genina O, Pines M. Halevy O, et al. Among authors: pines m. Biochem Pharmacol. 1996 Oct 11;52(7):1057-63. doi: 10.1016/0006-2952(96)00427-3. Biochem Pharmacol. 1996. PMID: 8831725

3

Inhibition of collagen synthesis, smooth muscle cell proliferation, and injury-induced intimal hyperplasia by halofuginone.

Nagler A, Miao HQ, Aingorn H, Pines M, Genina O, Vlodavsky I. Nagler A, et al. Among authors: pines m. Arterioscler Thromb Vasc Biol. 1997 Jan;17(1):194-202. doi: 10.1161/01.atv.17.1.194. Arterioscler Thromb Vasc Biol. 1997. PMID: 9012656

4

Halofuginone: a novel antifibrotic therapy.

Pines M, Nagler A. Pines M, et al. Gen Pharmacol. 1998 Apr;30(4):445-50. doi: 10.1016/s0306-3623(97)00307-8. Gen Pharmacol. 1998. PMID: 9522159 Review.

5

Halofuginone--an inhibitor of collagen type I synthesis--prevents postoperative formation of abdominal adhesions.

Nagler A, Rivkind AI, Raphael J, Levi-Schaffer F, Genina O, Lavelin I, Pines M. Nagler A, et al. Among authors: pines m. Ann Surg. 1998 Apr;227(4):575-82. doi: 10.1097/00000658-199804000-00021. Ann Surg. 1998. PMID: 9563549 Free PMC article.

6

Halofuginone, an inhibitor of collagen type I synthesis, prevents postoperative adhesion formation in the rat uterine horn model.

Nagler A, Genina O, Lavelin I, Ohana M, Pines M. Nagler A, et al. Among authors: pines m. Am J Obstet Gynecol. 1999 Mar;180(3 Pt 1):558-63. doi: 10.1016/s0002-9378(99)70254-1. Am J Obstet Gynecol. 1999. PMID: 10076128

7

Inhibition of bladder carcinoma angiogenesis, stromal support, and tumor growth by halofuginone.

Elkin M, Ariel I, Miao HQ, Nagler A, Pines M, de-Groot N, Hochberg A, Vlodavsky I. Elkin M, et al. Among authors: pines m. Cancer Res. 1999 Aug 15;59(16):4111-8. Cancer Res. 1999. PMID: 10463616

8

Inhibition of matrix metalloproteinase-2 expression and bladder carcinoma metastasis by halofuginone.

Elkin M, Reich R, Nagler A, Aingorn E, Pines M, de-Groot N, Hochberg A, Vlodavsky I. Elkin M, et al. Among authors: pines m. Clin Cancer Res. 1999 Aug;5(8):1982-8. Clin Cancer Res. 1999. PMID: 10473075

9

Topical treatment of cutaneous chronic graft versus host disease with halofuginone: a novel inhibitor of collagen type I synthesis.

Nagler A, Pines M. Nagler A, et al. Among authors: pines m. Transplantation. 1999 Dec 15;68(11):1806-9. doi: 10.1097/00007890-199912150-00027. Transplantation. 1999. PMID: 10609960

10

The effect of halofuginone, an inhibitor of collagen type i synthesis, on urethral stricture formation: in vivo and in vitro study in a rat model.

Nagler A, Gofrit O, Ohana M, Pode D, Genina O, Pines M. Nagler A, et al. Among authors: pines m. J Urol. 2000 Nov;164(5):1776-80. J Urol. 2000. PMID: 11025768

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

235 results

Search Page

Filters